Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AQUAGAIN - FOLDING SMED A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.6% 1.6% 1.6% 1.6% 1.6% 1.6% 1.6% 1.6%   Bankruptcy risk   2.0% 2.1% 2.6% 3.4% 2.9% 1.7% 6.6% 6.6%   Credit score (0-100)   71 67 60 53 57 73 36 36   Credit rating   A A BBB BBB BBB A BBB BBB   Credit limit (kDKK)   3.1 1.7 0.0 0.0 0.0 31.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   29,856 32,462 28,134 34,873 37,261 42,674 0.0 0.0   EBITDA   3,410 5,706 -966 3,082 2,510 5,715 0.0 0.0   EBIT   2,886 5,158 -1,438 2,653 2,115 5,364 0.0 0.0   Pre-tax profit (PTP)   2,033.3 4,466.5 -1,978.5 1,479.4 1,105.6 4,399.9 0.0 0.0   Net earnings   2,150.7 3,251.3 -1,441.8 1,067.7 979.9 3,398.5 0.0 0.0   Pre-tax profit without non-rec. items   2,033 4,466 -1,979 1,479 1,106 4,400 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   1,709 1,505 1,150 1,167 1,174 975 0.0 0.0   Shareholders equity total   11,091 14,389 11,873 12,983 14,000 17,603 16,603 16,603   Interest-bearing liabilities   4,234 5,340 6,847 10,846 7,051 7,153 0.0 0.0   Balance sheet total (assets)   29,110 38,808 34,127 53,841 48,870 52,873 16,603 16,603   Net Debt   3,308 4,424 5,675 5,624 1,690 -459 -16,603 -16,603     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   29,856 32,462 28,134 34,873 37,261 42,674 0.0 0.0   Gross profit growth   6.4% 8.7% -13.3% 24.0% 6.8% 14.5% -100.0% 0.0%   Employees   49 51 55 58 61 58 0 0   Employee growth %   -7.5% 4.1% 7.8% 5.5% 5.2% -4.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   29,110 38,808 34,127 53,841 48,870 52,873 16,603 16,603   Balance sheet change%   -10.0% 33.3% -12.1% 57.8% -9.2% 8.2% -68.6% 0.0%   Added value   3,409.6 5,705.7 -965.6 3,082.5 2,545.1 5,715.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -806 -752 -827 -413 -388 -550 -975 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   9.7% 15.9% -5.1% 7.6% 5.7% 12.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.7% 15.4% -3.9% 6.4% 4.4% 11.4% 0.0% 0.0%   ROI %   18.1% 27.3% -6.2% 11.7% 9.3% 22.8% 0.0% 0.0%   ROE %   21.5% 25.5% -11.0% 8.6% 7.3% 21.5% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   38.1% 37.1% 34.8% 24.1% 28.6% 33.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   97.0% 77.5% -587.8% 182.4% 67.3% -8.0% 0.0% 0.0%   Gearing %   38.2% 37.1% 57.7% 83.5% 50.4% 40.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   14.8% 15.8% 9.3% 15.1% 12.9% 19.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.3 1.5 1.5 1.3 1.3 1.6 0.0 0.0   Current Ratio   1.5 1.7 1.8 1.4 1.5 1.7 0.0 0.0   Cash and cash equivalent   925.8 916.4 1,172.2 5,222.3 5,360.6 7,612.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   9,489.6 15,979.5 14,546.9 15,986.7 16,052.6 21,872.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   70 112 -18 53 42 99 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   70 112 -18 53 41 99 0 0   EBIT / employee   59 101 -26 46 35 92 0 0   Net earnings / employee   44 64 -26 18 16 59 0 0